Coronary stents: in these days of climate change should all stents wear coats?
作者信息
Lowe R, Menown I B A, Nogareda G, Penn I M
机构信息
Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada.
出版信息
Heart. 2005 Jun;91 Suppl 3(Suppl 3):iii20-3. doi: 10.1136/hrt.2005.060269.
Abstract
摘要
相似文献
1
Coronary stents: in these days of climate change should all stents wear coats?冠状动脉支架：在当今气候变化的时代，所有的支架都应该穿上“外套”吗？
Heart. 2005 Jun;91 Suppl 3(Suppl 3):iii20-3. doi: 10.1136/hrt.2005.060269.
2
[Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide].
Arq Bras Cardiol. 2004 Dec;83 Spec No:59-63. Epub 2004 Dec 13.
3
Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.碳化硅涂层冠状动脉支架在血小板激活过程中具有较低的血小板和白细胞粘附性。
J Investig Med. 1999 Jul;47(6):304-10.
4
Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: two-year results of the ENERGY Registry.用于经皮冠状动脉介入治疗的碳化硅涂层钴铬裸金属支架的前瞻性多中心评估：ENERGY注册研究的两年结果
Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):381-7. doi: 10.1016/j.carrev.2014.10.002. Epub 2014 Oct 15.
5
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).佐他莫司洗脱磷酸胆碱涂层钴铬合金支架用于初发冠状动脉病变的血管内超声详细分析（来自ENDEAVOR II试验的结果）
Am J Cardiol. 2007 Sep 1;100(5):818-23. doi: 10.1016/j.amjcard.2007.04.016. Epub 2007 Jun 14.
6
Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.非晶态碳化硅、镁合金、不锈钢和钴铬合金支架表面上血小板黏附与血栓激活的差异
Catheter Cardiovasc Interv. 2009 Mar 1;73(4):488-96. doi: 10.1002/ccd.21834.
7
Histological analysis of cobalt-chromium stents with and without Camouflage® polymer coating: experimental porcine carotid artery model.
Vascular. 2011 Apr;19(2):89-96. doi: 10.1258/vasc.2010.oa0268.
8
A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.一项随机试验，比较磷酸胆碱涂层支架置入术与球囊血管成形术以及阿昔单抗与安慰剂在减少小冠状动脉再狭窄方面的效果。
J Intern Med. 2004 Nov;256(5):388-97. doi: 10.1111/j.1365-2796.2004.01398.x.
9
Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
Catheter Cardiovasc Interv. 2007 May 1;69(6):799-800. doi: 10.1002/ccd.21057.
10
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study.第三代药物洗脱 Orsiro 支架治疗单支初发冠状动脉病变的临床和血管造影经验（BIOFLOW-I）：一项前瞻性、首例人体研究。
EuroIntervention. 2013 Jan 22;8(9):1006-11. doi: 10.4244/EIJV8I9A155.
引用本文的文献
1
Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points.他克莫司洗脱碳涂覆支架与西罗莫司洗脱支架在预防症状驱动的临床终点方面的比较。
Clin Res Cardiol. 2010 Oct;99(10):645-50. doi: 10.1007/s00392-010-0165-3. Epub 2010 Apr 20.
本文引用的文献
1
Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.释放一氧化氮的生物聚合物可抑制绵羊动静脉搭桥移植模型中的血栓形成。
J Vasc Surg. 2004 Oct;40(4):803-11. doi: 10.1016/j.jvs.2004.07.007.
2
In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits.
Radiology. 2004 Feb;230(2):377-82. doi: 10.1148/radiol.2302020417. Epub 2003 Dec 29.
3
Usefulness of a cobalt chromium coronary stent alloy.钴铬冠状动脉支架合金的效用。
Am J Cardiol. 2003 Aug 15;92(4):463-6. doi: 10.1016/s0002-9149(03)00669-6.
4
Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients.肝素涂层支架置入术治疗有症状患者小冠状动脉狭窄
Circulation. 2003 Mar 11;107(9):1265-70. doi: 10.1161/01.cir.0000053442.64637.34.
5
Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.紫杉醇衍生物洗脱聚合物支架系统植入人体后晚期支架内再狭窄的机制
Circulation. 2002 Nov 19;106(21):2649-51. doi: 10.1161/01.cir.0000041632.02514.14.
6
Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study.
Int J Cardiovasc Intervent. 2000 Dec;3(4):215-225. doi: 10.1080/14628840050515966.
7
Long-term stability of a coronary stent coating post-implantation.冠状动脉支架涂层植入后的长期稳定性。
J Biomed Mater Res. 2002;63(6):699-705. doi: 10.1002/jbm.10387.
8
Carbon coating of stents has no effect on inflammatory response to primary stent deployment.支架的碳涂层对初次支架植入的炎症反应没有影响。
Angiology. 2002 Sep-Oct;53(5):563-8. doi: 10.1177/000331970205300510.
9
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.在猪冠状动脉模型中，植入雌激素洗脱、磷酸胆碱涂层支架与新生内膜形成减少相关，但血管修复未延迟。
Catheter Cardiovasc Interv. 2002 Oct;57(2):266-71. doi: 10.1002/ccd.10339.
10
Does stent design affect the long-term outcome after coronary stenting?
Catheter Cardiovasc Interv. 2002 Jul;56(3):305-11. doi: 10.1002/ccd.10240.
Zotero 插件